Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI

Gastroenterology

Volumn 118, Issue 2, 2000, Pages 264-273

  Lochs, Herbert ^a,b   Mayer, Michael ^c   Fleig, Wolfgang E ^d   Mortensen, Per Brobech ^e   Bauer, Peter ^f   Genser, Dieter ^b   Petritsch, Wolfgang ^g   Raithel, Martin ^h   Hoffmann, Rainer ⁱ   Gross, V ^j   Plauth, Mathias ^k   Staun, Michael ^e   Nesje, Lars Birger ^l  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF COLOGNE   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY HOSPITAL GRAZ   (Austria)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ KLINIKUM ESSLINGEN   (Germany)

^j UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^k UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^l HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; METRONIDAZOLE; PLACEBO; STEROID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK FACTOR; TREATMENT INDICATION;

EID: 0033965199     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70208-3     Document Type: Article

References (31)